Anonymous
Guest
Anonymous
Guest
LONDON (Dow Jones)--AstraZeneca PLC (AZN.LN), a global research-based biopharmaceutical company, said Monday that on Sept. 16, it purchased for cancellation 750,000 ordinary shares of AstraZeneca PLC at a price of 2826 pence per share.
MAIN FACTS:
-Upon the cancellation of these shares, the number of shares in issue will be 1,336,347,845.
-Shares at 0830 GMT down 41 pence, or 1.5%, at 281 pence, valuing the company at GBP37.54 billion.
http://online.wsj.com/article/BT-CO-20110919-702092.html?mod=WSJ_qtoverview_wsjlatest
MAIN FACTS:
-Upon the cancellation of these shares, the number of shares in issue will be 1,336,347,845.
-Shares at 0830 GMT down 41 pence, or 1.5%, at 281 pence, valuing the company at GBP37.54 billion.
http://online.wsj.com/article/BT-CO-20110919-702092.html?mod=WSJ_qtoverview_wsjlatest